Literature DB >> 12808285

The presence of ceramidase activity in liver nuclear membrane.

Takayuki Shiraishi1, Shinichiro Imai, Yutaka Uda.   

Abstract

This report presents a demonstration of ceramidase activity in the nuclear membrane or envelope of mammalian livers. The products of ceramidase reaction were identified by means of TLC for released fatty acid and HPLC for sphingosine. The ceramidase activity was maximum over a broad neutral to alkaline region ranging from pH 7.0 to 8.8. This activity was inhibited by N-oleoylethanolamine known as a specific inhibitor for ceramidase and by anandamide to a similar extent. The enzymatic study suggests that the nuclear ceramidase has different properties from other ceramidase reported previously. As sphingomyelinase, one of enzymes involved in the sphingomyelin cycle, are known to be present in the nuclear membrane, it is now evident that at least two enzymes involved in the sphingomyelin cycle are present in the nuclear membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808285     DOI: 10.1248/bpb.26.775

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  11 in total

Review 1.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

Review 2.  Nuclear sphingolipid metabolism.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Annu Rev Physiol       Date:  2011-09-09       Impact factor: 19.318

Review 3.  Mitochondrial ceramide and the induction of apoptosis.

Authors:  Leah J Siskind
Journal:  J Bioenerg Biomembr       Date:  2005-06       Impact factor: 2.945

Review 4.  The interplay between bioactive sphingolipids and steroid hormones.

Authors:  Natasha C Lucki; Marion B Sewer
Journal:  Steroids       Date:  2010-02-04       Impact factor: 2.668

5.  Improved synthesis of a fluorogenic ceramidase substrate.

Authors:  Zuping Xia; Jeremiah M Draper; Charles D Smith
Journal:  Bioorg Med Chem       Date:  2010-01-06       Impact factor: 3.641

Review 6.  Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression.

Authors:  Panfeng Fu; David L Ebenezer; Alison W Ha; Vidyani Suryadevara; Anantha Harijith; Viswanathan Natarajan
Journal:  J Cell Biochem       Date:  2018-05-08       Impact factor: 4.429

7.  Acid ceramidase treatment enhances the outcome of autologous chondrocyte implantation in a rat osteochondral defect model.

Authors:  M E Frohbergh; J M Guevara; R P Grelsamer; M F Barbe; X He; C M Simonaro; E H Schuchman
Journal:  Osteoarthritis Cartilage       Date:  2015-10-30       Impact factor: 6.576

Review 8.  Nuclear sphingolipids: metabolism and signaling.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  J Lipid Res       Date:  2008-03-09       Impact factor: 5.922

Review 9.  Ceramide function in the brain: when a slight tilt is enough.

Authors:  Chiara Mencarelli; Pilar Martinez-Martinez
Journal:  Cell Mol Life Sci       Date:  2012-06-24       Impact factor: 9.261

Review 10.  The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.

Authors:  Nitai C Hait; Aparna Maiti
Journal:  Mediators Inflamm       Date:  2017-11-15       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.